GlassScriptPhysician profile
Gregory L Lynch
NPI 1477818805
$11,782.90
in general payments reported to CMS, 2019-2025
29 companies · $468 in 2025
The $468 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.78 · 2020: $41.15 · 2021: $56.37 · 2022: $91.05 · 2023: $11K · 2024: $521 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Food and Beverage: $1,541 · Travel and Lodging: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Food and Beverage | $1,541.19 |
| Travel and Lodging | $1,524.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,380.33 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Baxter Healthcare | $356.55 | 2024-2025 | Perclot, Recothrom |
| Pfizer INC. | $157.80 | 2024 | |
| Merck Sharp & Dohme LLC | $97.56 | 2023-2025 | Keytruda, Lynparza, Bridion |
| Tactile Systems Technology INC | $88.24 | 2023-2024 | Flexitouch Plus, Entre Plus |
| Abiomed | $69.89 | 2023-2024 | Impella |
| Organogenesis INC. | $59.43 | 2025 | Puraply Wound Matrix |
| Innocoll Pharmaceuticals Limited | $58.33 | 2021-2022 | |
| Convatec INC. | $47.60 | 2023 | |
| Stryker Corporation | $45.24 | 2025 | Stryker |
| Solventum Corporation | $32.90 | 2024 | Prevena, V.A.C. Veraflo |
| Innovation Technologies INC | $32.45 | 2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $30.99 | 2025 | |
| Kci USA, INC. | $30.87 | 2020-2021 | |
| Abbvie INC. | $29.98 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $29.62 | 2023 | Barostim Neo System |
| Hologic Sales and Service, LLC | $26.45 | 2025 | Magtrace, Magseed |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.47 | 2024 | Caplyta |
| Medtronic, INC. | $21.49 | 2025 | Clydesdale Ptc Spinal System |
| Merit Medical Systems INC | $20.44 | 2022 | |
| Leica Microsystems INC. | $19.98 | 2022 | |
| Davol INC. | $19.17 | 2022 | |
| Elucent Medical | $18.90 | 2025 | |
| Midsouth Orthopedics INC. | $14.82 | 2019 | |
| Polynovo North America LLC | $14.66 | 2025 | Novosorb Btm |
| Bioptics, INC. | $14.58 | 2021 | |
| Ethicon US, LLC | $14.00 | 2020 | |
| Shire North American Group INC | $13.96 | 2019 | |
| Boston Scientific Corporation | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.